262 Hawkins Store Rd Kennesaw, GA 30144
This exceptional 5,485 square foot, two-story inpatient residential facility presents a unique investment opportunity in Kennesaw, Georgia. Situated on a spacious 3.25-acre lot at 262 Hawkins Store Rd NE, 30144, this property boasts 11 bedrooms and 5 bathrooms, along with an office, large conference room, and well-appointed kitchen. Currently configured as a MARR Certified Drug Treatment Facility, the property's R-20 zoning allows for flexibility in future uses, including senior living or other residential and community-oriented developments. A grandfathered provision permits continued use as a drug treatment facility. The building was constructed in 2023 and features a layout designed to accommodate the needs of residents, with potential for expansion to 22 beds. The property's strategic location in Kennesaw, an area lacking residential drug treatment facilities, offers significant potential for growth and community impact. The asking price is $1,200,000, translating to $218.78 per square foot and $109,090.91 per unit. The property's strong location is supported by a high concentration of affluent households within a 5-mile radius: 10,918 households with a net worth exceeding $1,000,000 and 12,067 households with an income over $100,000. Average home values within 5 miles are $371,250. The property's APN is 16021000140.
-
Genesis Ministries Church
-
Genesis Ministries - New Beginnings Rehabilitation Center Church
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendComparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
No recorded transactions found for this property.
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.